Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  80 results for ""Cystadenocarcinoma, Serous""

Your Filters

Publication : international journal of cancer
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

B cells critical for outcome in high grade serous ovarian carcinoma.

  • Authors : Vledder A; Department of Obstetrics and Gynecology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.; Paijens ST

Subjects: Ovarian Neoplasms*/Ovarian Neoplasms*/Ovarian Neoplasms*/pathology ; Ovarian Neoplasms*/Ovarian Neoplasms*/Ovarian Neoplasms*/immunology ; Ovarian Neoplasms*/Ovarian Neoplasms*/Ovarian Neoplasms*/mortality

  • Source: International journal of cancer [Int J Cancer] 2024 Dec 15; Vol. 155 (12), pp. 2265-2276. Date of Electronic Publication: 2024 Aug 22.Publisher: Wiley-Liss Country of Publication: United States NLM ID: 0042124 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Targeted DNA sequencing of high-grade serous ovarian carcinoma reveals association of TP53 mutations with platinum resistance when combined with gene expression.

  • Authors : Holý P; Toxicogenomics Unit, National Institute of Public Health, Prague, Czech Republic.; Biomedical Center, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic.

Subjects: Ovarian Neoplasms*/Ovarian Neoplasms*/Ovarian Neoplasms*/genetics ; Ovarian Neoplasms*/Ovarian Neoplasms*/Ovarian Neoplasms*/drug therapy ; Ovarian Neoplasms*/Ovarian Neoplasms*/Ovarian Neoplasms*/pathology

  • Source: International journal of cancer [Int J Cancer] 2024 Jul 01; Vol. 155 (1), pp. 104-116. Date of Electronic Publication: 2024 Mar 06.Publisher: Wiley-Liss Country of Publication: United States NLM ID: 0042124 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Trps1 predicts poor prognosis in advanced high grade serous ovarian carcinoma.

  • Authors : Wang X; Key Laboratory of Stem Cell Engineering and Regenerative Medicine of Fujian Province University, Fujian Medical University, Fuzhou, China.; Department of Molecular Pathology, Fujian Medical University Cancer Hospital, Fujian Cancer Hospital, Fuzhou, China.

Subjects: Cystadenocarcinoma, Serous*/Cystadenocarcinoma, Serous*/Cystadenocarcinoma, Serous*/pathology ; Ovarian Neoplasms*/Ovarian Neoplasms*/Ovarian Neoplasms*/pathology; Male

  • Source: International journal of cancer [Int J Cancer] 2024 May 01; Vol. 154 (9), pp. 1639-1651. Date of Electronic Publication: 2024 Jan 11.Publisher: Wiley-Liss Country of Publication: United States NLM ID: 0042124 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Unveiling the epigenomic mechanisms of acquired platinum-resistance in high-grade serous ovarian cancer.

  • Authors : Silva R; Cancer Biology and Therapeutics Laboratory, UCD Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Dublin, Ireland.; Systems Biology Ireland, UCD School of Medicine, University College Dublin, Dublin, Ireland.

Subjects: Ovarian Neoplasms*/Ovarian Neoplasms*/Ovarian Neoplasms*/drug therapy ; Ovarian Neoplasms*/Ovarian Neoplasms*/Ovarian Neoplasms*/genetics ; Ovarian Neoplasms*/Ovarian Neoplasms*/Ovarian Neoplasms*/pathology

  • Source: International journal of cancer [Int J Cancer] 2023 Jul 01; Vol. 153 (1), pp. 120-132. Date of Electronic Publication: 2023 Mar 20.Publisher: Wiley-Liss Country of Publication: United States NLM ID: 0042124 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Integrated molecular profiling of patient-derived ovarian cancer models identifies clinically relevant signatures and tumor vulnerabilities.

  • Authors : Lupia M; Unit of Gynaecological Oncology Research, European Institute of Oncology IRCCS, Milan, Italy.; Melocchi V

Subjects: Cystadenocarcinoma, Serous* ; Ovarian Neoplasms*/Ovarian Neoplasms*/Ovarian Neoplasms*/genetics ; Ovarian Neoplasms*/Ovarian Neoplasms*/Ovarian Neoplasms*/pathology

  • Source: International journal of cancer [Int J Cancer] 2022 Jul 15; Vol. 151 (2), pp. 240-254. Date of Electronic Publication: 2022 Mar 14.Publisher: Wiley-Liss Country of Publication: United States NLM ID: 0042124 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Improved long-term survival of corpus cancer in Japan: A 40-year population-based analysis.

  • Authors : Yagi A; Department of Obstetrics and Gynecology, Osaka University Graduate School of Medicine, Osaka, Japan.; Ueda Y

Subjects: Adenocarcinoma, Clear Cell/Adenocarcinoma, Clear Cell/Adenocarcinoma, Clear Cell/*mortality ; Adenocarcinoma, Mucinous/Adenocarcinoma, Mucinous/Adenocarcinoma, Mucinous/*mortality ; Cystadenocarcinoma, Serous/Cystadenocarcinoma, Serous/Cystadenocarcinoma, Serous/*mortality

  • Source: International journal of cancer [Int J Cancer] 2022 Jan 15; Vol. 150 (2), pp. 232-242. Date of Electronic Publication: 2021 Sep 15.Publisher: Wiley-Liss Country of Publication: United States NLM ID: 0042124 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Expression profiles of PRKG1, SDF2L1 and PPP1R12A are predictive and prognostic factors for therapy response and survival in high-grade serous ovarian cancer.

Subjects: Cyclic GMP-Dependent Protein Kinase Type I/Cyclic GMP-Dependent Protein Kinase Type I/Cyclic GMP-Dependent Protein Kinase Type I/*genetics ; Cystadenocarcinoma, Serous/Cystadenocarcinoma, Serous/Cystadenocarcinoma, Serous/*drug therapy ; Gene Expression Profiling/Gene Expression Profiling/Gene Expression Profiling/*methods

  • Source: International journal of cancer [Int J Cancer] 2020 Jul 15; Vol. 147 (2), pp. 565-574. Date of Electronic Publication: 2020 Mar 13.Publisher: Wiley-Liss Country of Publication: United States NLM ID: 0042124 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Genomic profiling of the residual disease of advanced high-grade serous ovarian cancer after neoadjuvant chemotherapy.

  • Authors : Lee YJ; Department of Obstetrics and Gynecology, Institute of Women's Life Medical Science, Yonsei University College of Medicine, Seoul, Republic of Korea.; Kim D

Subjects: Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/*pharmacology ; Cystadenocarcinoma, Serous/Cystadenocarcinoma, Serous/Cystadenocarcinoma, Serous/*genetics ; Ovarian Neoplasms/Ovarian Neoplasms/Ovarian Neoplasms/*genetics

  • Source: International journal of cancer [Int J Cancer] 2020 Apr 01; Vol. 146 (7), pp. 1851-1861. Date of Electronic Publication: 2019 Nov 23.Publisher: Wiley-Liss Country of Publication: United States NLM ID: 0042124 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Boosting the apoptotic response of high-grade serous ovarian cancers with CCNE1 amplification to paclitaxel in vitro by targeting APC/C and the pro-survival protein MCL-1.

  • Authors : Raab M; Department of Gynecology, Goethe-University, Frankfurt, Germany.; Kobayashi NF

Subjects: Anaphase-Promoting Complex-Cyclosome/Anaphase-Promoting Complex-Cyclosome/Anaphase-Promoting Complex-Cyclosome/*antagonists & inhibitors ; Cyclin E/Cyclin E/Cyclin E/*genetics ; Cystadenocarcinoma, Serous/Cystadenocarcinoma, Serous/Cystadenocarcinoma, Serous/*drug therapy

  • Source: International journal of cancer [Int J Cancer] 2020 Feb 15; Vol. 146 (4), pp. 1086-1098. Date of Electronic Publication: 2019 Jul 22.Publisher: Wiley-Liss Country of Publication: United States NLM ID: 0042124 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

miR-181a overexpression predicts the poor treatment response and early-progression of serous ovarian cancer patients.

  • Authors : Panoutsopoulou K; Department of Biochemistry and Molecular Biology, Faculty of Biology, National and Kapodistrian University of Athens, Athens, Greece.; Avgeris M

Subjects: Up-Regulation*; Biomarkers, Tumor/Biomarkers, Tumor/Biomarkers, Tumor/*genetics ; Cystadenocarcinoma, Serous/Cystadenocarcinoma, Serous/Cystadenocarcinoma, Serous/*therapy

  • Source: International journal of cancer [Int J Cancer] 2020 Dec 15; Vol. 147 (12), pp. 3560-3573. Date of Electronic Publication: 2020 Aug 01.Publisher: Wiley-Liss Country of Publication: United States NLM ID: 0042124 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
  • 1-10 of  80 results for ""Cystadenocarcinoma, Serous""